Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
13h
New Scientist on MSNStrongest evidence yet that Ozempic and Wegovy reduce alcohol intakeThe drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
20h
News Nation on MSNStudy finds rare vision issues in taking GLP-1 weight loss drugsAlthough reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...
Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results